Targeted alpha therapy for chronic lymphocytic leukaemia and non-Hodgkin’s lymphoma with the anti-CD37 radioimmunoconjugate 212Pb-NNV003
Astri Fjelde Maaland(University of Oslo), Jostein Dahle(Oslo University Hospital), Tania A. Rozgaja Stallons(Orano (United States)), Helèn Heyerdahl(Nordic Nanovector (Norway)), Arne Kolstad(Oslo University Hospital), Julien Torgue(Orano (France)), Amal Saidi(Orano (France))
Cited by 39
Related Papers
Tisagenlecleucel in adult relapsed or refractory follicular lymphoma: the phase 2 ELARA trial
|Nature Medicine|2021|523
DISTRIBUTION OF 5‐AMINOLEVULINIC ACID‐INDUCED PORPHYRINS IN NODULOULCERATIVE BASAL CELL CARCINOMA
|Photochemistry and Photobiology|1995|181